Luther King Capital Management (LKCM)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-572
| Closed | -$201K | – | 613 |
|
2023
Q2 | $201K | Sell |
572
-682
| -54% | -$240K | ﹤0.01% | 577 |
|
2023
Q1 | $395K | Buy |
1,254
+6
| +0.5% | +$1.89K | ﹤0.01% | 487 |
|
2022
Q4 | $360K | Buy |
1,248
+31
| +3% | +$8.95K | ﹤0.01% | 494 |
|
2022
Q3 | $352K | Buy |
1,217
+270
| +29% | +$78.1K | ﹤0.01% | 489 |
|
2022
Q2 | $267K | Buy |
+947
| New | +$267K | ﹤0.01% | 557 |
|